Cargando…

Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial

INTRODUCTION: Atacicept is a soluble, fully human, recombinant fusion protein that inhibits B cell-stimulating factors APRIL (a proliferation-inducing ligand) and BLyS (B-lymphocyte stimulator). The APRIL- LN study aimed to evaluate the efficacy and safety of atacicept in patients with active lupus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ginzler, Ellen M, Wax, Stephen, Rajeswaran, Anand, Copt, Samuel, Hillson, Jan, Ramos, Eleanor, Singer, Nora G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392829/ https://www.ncbi.nlm.nih.gov/pubmed/22325903 http://dx.doi.org/10.1186/ar3738

Ejemplares similares

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)

Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
por: Isenberg, David, et al.
Publicado: (2014)

Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
por: Isenberg, David, et al.
Publicado: (2015)

Profile of atacicept and its potential in the treatment of systemic lupus erythematosus
por: Cogollo, Estafania, et al.
Publicado: (2015)

Profile of atacicept and its potential in the treatment of systemic lupus erythematosus [Corrigendum]
Publicado: (2015)

Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
por: Falcini, FF, et al.
Publicado: (2008)

Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials
por: Pitsiu, Maria, et al.
Publicado: (2023)

Integrated safety profile of atacicept: an analysis of pooled data from the atacicept clinical trial programme
por: Gordon, Caroline, et al.
Publicado: (2019)

Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty‐Four–Week, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Arm, Phase IIb Study
por: Merrill, Joan T., et al.
Publicado: (2018)

Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
por: Silva, Hélio Tedesco, et al.
Publicado: (2014)

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
por: Isenberg, David, et al.
Publicado: (2010)

Site-specific N- and O-glycosylation analysis of atacicept
por: Stavenhagen, Kathrin, et al.
Publicado: (2019)

Kinetics of free and ligand-bound atacicept in human serum
por: Eslami, Mahya, et al.
Publicado: (2022)

Post Hoc Analysis of the Phase II/III APRIL‐SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL
por: Gordon, Caroline, et al.
Publicado: (2016)

Safety and Efficacy of Atacicept in Combination With Rituximab for Reducing the Signs and Symptoms of Rheumatoid Arthritis: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Pilot Trial
por: van Vollenhoven, R. F., et al.
Publicado: (2015)

An Exploratory Dose-Escalating Study Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous Atacicept in Patients with Systemic Lupus Erythematosus
por: Pena-Rossi, C, et al.
Publicado: (2009)

Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies
por: Studham, Matthew, et al.
Publicado: (2023)

Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2020)

No interactions between heparin and atacicept, an antagonist of B cell survival cytokines
por: Kowalczyk‐Quintas, Christine, et al.
Publicado: (2019)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021)

Dialogue: commentary on ‘Engaging African-ancestry participants in systemic lupus erythematosus clinic trials’
por: Ginzler, Ellen M
Publicado: (2018)

Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis
por: Ostalska-Nowicka, Danuta, et al.
Publicado: (2011)

Physical and Chemical Stability of Mycophenolate Mofetil (MMF) Suspension Prepared at the Hospital
por: Fahimi, Fanak, et al.
Publicado: (2012)

Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
por: Isenberg, David A., et al.
Publicado: (2020)

Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis
por: Singh, Jasvinder A., et al.
Publicado: (2016)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Recognition of M.M.F. under the Schedule to the Indian Medical Council Act
por: Sinha, Abodh Kumar
Publicado: (1948)

Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS)
por: Berger, Amnon A., et al.
Publicado: (2021)

CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS
por: Kumar, Gaurav, et al.
Publicado: (2021)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

The Role of Cytokine in the Lupus Nephritis
por: Iwata, Yasunori, et al.
Publicado: (2011)

Chapter 12: Lupus nephritis
Publicado: (2012)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

The Role of Autophagy in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a3267cf5qsnkptjs90qq2ddgqe